Wird geladen...
Toxicity of Immune Checkpoint Inhibitors: Considerations for the Surgeon
BACKGROUND. The use of immunotherapeutic agents, specifically immune checkpoint inhibitors (ICIs) for solid malignancies, is rapidly rising, and many new agents and treatment combinations are in development. However, ICIs have a unique side-effect profile of immune-related adverse events (irAEs) com...
Gespeichert in:
| Veröffentlicht in: | Ann Surg Oncol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7594106/ https://ncbi.nlm.nih.gov/pubmed/31965370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-08183-0 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|